Carboplatin - Wikipedia, the free encyclopedia
5 Aug 2009 ... Carboplatin is a chemotherapy drug used against some forms of cancer (mainly ovarian carcinoma, lung, head and neck cancers). ...
http://en.wikipedia.org/wiki/Carboplatin...
|
Carboplatin: MedlinePlus Drug Information
Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related ...
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a695017.htm...
|
ACS :: Cancer Drug Guide: carboplatin
Carboplatin is a platinum chemotherapy drug that belongs to a group of drugs known as alkylating agents. It stops the growth of cancer cells, ...
http://www.cancer.org/docroot/CDG/content/CDG_carboplatin.as...
|
BioMed Central | Full text | DNA damage induced by cis- and ...
DNA damage after a one day treatment with cis- or carboplatin correlated well with the .... DNA damage induced by the crosslinkers cis- and carboplatin was ...
http://www.biomedcentral.com/1471-2407/9/359...
|
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
RESULTS: The 12-month rates of progression-free survival were 24.9% with gefitinib and 6.7% with carboplatin-paclitaxel. The study met its primary objective ...
http://www.ncbi.nlm.nih.gov/pubmed/19692680...
|
Carboplatin--R&S PharmChem Co.,Ltd.
Carboplatin ( KAR-boe-pla-tin) belongs to the group of medicines known as alkylating agents. It is used to treat cancer of the ovaries. ...
http://www.rspharmchem.com/carboplatin.htm...
|
Radiotherapy versus single-dose carboplatin in adjuvant treatment ...
After good results in initial studies with one injection of carboplatin, we undertook a large randomised trial to compare the approaches of radiotherapy ...
http://www.ncbi.nlm.nih.gov/pubmed/16039331...
|
A randomised study of carboplatin vs sequential ifosfamide ...
In a study designed to compare response rates of patients with stage III epithelial ovarian carcinoma to ifosfamide and carboplatin, 152 patients were ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19...
|
Paclitaxel-carboplatin alone or with bevacizumab for non-small ...
CONCLUSIONS: The addition of bevacizumab to paclitaxel plus carboplatin in the treatment of selected patients with non-small-cell lung cancer has a ...
http://www.ncbi.nlm.nih.gov/pubmed/17167137...
|
Phase II Trial of Carboplatin and Paclitaxel in Papillary Renal ...
8 Jul 2009 ... Abstract and Introduction: Cytotoxic chemotherapy has not been well investigated in non-clear-cell renal cell carcinoma (RCC), ...
http://www.medscape.com/viewarticle/705131...
|